GlassScriptPhysician profile
Augustus Demanes
NPI 1295298693
$30,516.23
in general payments reported to CMS, 2019-2025
11 companies · $12K in 2025
The $12K reported for 2025 was more than what 88% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $5,892 · 2023: $1,713 · 2024: $11K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Food and Beverage: $6,580 · Travel and Lodging: $2,887 · Education: $157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Food and Beverage | $6,580.21 |
| Travel and Lodging | $2,886.62 |
| Education | $157.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18,774.40 | 2024-2025 | Novostitch, Fast-Fix, Biosure |
| Stryker Corporation | $9,382.77 | 2022-2025 | Variax, Gamma, Iconix |
| Saxum Surgical, INC. | $1,396.87 | 2022-2023 | |
| Globus Medical, INC. | $262.33 | 2024 | Ankle Fracture System, Evo Retrograde, Troch Nail |
| Medacta USA, INC. | $251.00 | 2025 | Gmk Sphere |
| Zimmer Biomet Holdings, INC. | $175.73 | 2023-2024 | Persona, Affixus |
| Acera Surgical, INC. | $138.56 | 2025 | Restrata Wound Matrix |
| Depuy Synthes Sales INC. | $53.60 | 2024 | Na |
| Kci USA, INC. | $41.52 | 2022 | |
| Vericel Corporation | $24.61 | 2025 | Maci |
| Convatec INC. | $14.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Augustus Demanes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.